David N. Gill

Chief Financial Officer, NxStage Medical, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 17, 2026Granted 45,559 shares of Evolus, Inc.⁷
Sep 16, 2025Returned to company 25,080 shares of Y-mAbs Therapeutics, Inc.⁸
Sep 16, 2025Returned to company 5,825 shares at $8.60 of Y-mAbs Therapeutics, Inc.⁸
Jun 30, 2025Granted 25,080 shares of Y-mAbs Therapeutics, Inc.⁹
Mar 7, 2025Granted 7,364 shares of Evolus, Inc.¹⁰
Jun 11, 2024Granted 3,495 shares of Y-mAbs Therapeutics, Inc.¹¹
May 14, 2024Sold 6,718 shares at $12.60 of Evolus, Inc.¹²
May 13, 2024Sold 3,643 shares at $12.72 of Evolus, Inc.¹²
Feb 7, 2024Granted 6,464 shares of Evolus, Inc.¹³
Jun 8, 2023Granted 2,330 shares of Y-mAbs Therapeutics, Inc.¹⁴
Jan 27, 2023Granted 8,293 shares of Evolus, Inc.¹⁵
May 16, 2022Sold 5,000 shares at $13.62 of Evolus, Inc.¹⁶
May 13, 2022Sold 5,313 shares at $13.10 of Evolus, Inc.¹⁶
Jan 24, 2022Granted 15,568 shares of Evolus, Inc.¹⁷
Oct 5, 2021Returned to company 78,058 shares of CIK 1634432¹⁸
Oct 1, 2021Shares withheld for tax 17,763 shares at $2.06 of CIK 1634432¹⁹

The numbers on this page point here. Each one links to the record it came from.